381 related articles for article (PubMed ID: 26481629)
21. Expression of CYP11B2 in Aldosterone-Producing Adrenocortical Adenoma: Regulatory Mechanisms and Clinical Significance.
Nakamura Y; Yamazaki Y; Tezuka Y; Satoh F; Sasano H
Tohoku J Exp Med; 2016 Nov; 240(3):183-190. PubMed ID: 27853054
[TBL] [Abstract][Full Text] [Related]
22. Adrenal nodularity and somatic mutations in primary aldosteronism: one node is the culprit?
Dekkers T; ter Meer M; Lenders JW; Hermus AR; Schultze Kool L; Langenhuijsen JF; Nishimoto K; Ogishima T; Mukai K; Azizan EA; Tops B; Deinum J; Küsters B
J Clin Endocrinol Metab; 2014 Jul; 99(7):E1341-51. PubMed ID: 24758183
[TBL] [Abstract][Full Text] [Related]
23. Genetic and Histopathologic Intertumor Heterogeneity in Primary Aldosteronism.
Omata K; Yamazaki Y; Nakamura Y; Anand SK; Barletta JA; Sasano H; Rainey WE; Tomlins SA; Vaidya A
J Clin Endocrinol Metab; 2017 Jun; 102(6):1792-1796. PubMed ID: 28368480
[TBL] [Abstract][Full Text] [Related]
24. KCNJ5 mutation as a predictor for resolution of hypertension after surgical treatment of aldosterone-producing adenoma.
Kitamoto T; Omura M; Suematsu S; Saito J; Nishikawa T
J Hypertens; 2018 Mar; 36(3):619-627. PubMed ID: 29016532
[TBL] [Abstract][Full Text] [Related]
25. An update on novel mechanisms of primary aldosteronism.
Zennaro MC; Boulkroun S; Fernandes-Rosa F
J Endocrinol; 2015 Feb; 224(2):R63-77. PubMed ID: 25424518
[TBL] [Abstract][Full Text] [Related]
26. Double somatic mutations in
Nanba K; Blinder AR; Udager AM; Hirokawa Y; Miura T; Okuno H; Moriyoshi K; Yamazaki Y; Sasano H; Yasoda A; Satoh-Asahara N; Rainey WE; Tagami T
Front Endocrinol (Lausanne); 2024; 15():1286297. PubMed ID: 38505749
[TBL] [Abstract][Full Text] [Related]
27. Histopathological and genetic characterization of aldosterone-producing adenomas with concurrent subclinical cortisol hypersecretion: a case series.
Fallo F; Castellano I; Gomez-Sanchez CE; Rhayem Y; Pilon C; Vicennati V; Santini D; Maffeis V; Fassina A; Mulatero P; Beuschlein F; Reincke M
Endocrine; 2017 Dec; 58(3):503-512. PubMed ID: 28405879
[TBL] [Abstract][Full Text] [Related]
28. Biochemical, Histopathological, and Genetic Characterization of Posture-Responsive and Unresponsive APAs.
Guo Z; Nanba K; Udager A; McWhinney BC; Ungerer JPJ; Wolley M; Thuzar M; Gordon RD; Rainey WE; Stowasser M
J Clin Endocrinol Metab; 2020 Sep; 105(9):e3224-35. PubMed ID: 32516371
[TBL] [Abstract][Full Text] [Related]
29. Genetic Characteristics of Aldosterone-Producing Adenomas in Blacks.
Nanba K; Omata K; Gomez-Sanchez CE; Stratakis CA; Demidowich AP; Suzuki M; Thompson LDR; Cohen DL; Luther JM; Gellert L; Vaidya A; Barletta JA; Else T; Giordano TJ; Tomlins SA; Rainey WE
Hypertension; 2019 Apr; 73(4):885-892. PubMed ID: 30739536
[TBL] [Abstract][Full Text] [Related]
30. Genetic Characterization of GnRH/LH-Responsive Primary Aldosteronism.
Gagnon N; Cáceres-Gorriti KY; Corbeil G; El Ghoyareb N; Ludwig N; Latour M; Lacroix A; Bourdeau I
J Clin Endocrinol Metab; 2018 Aug; 103(8):2926-2935. PubMed ID: 29726953
[TBL] [Abstract][Full Text] [Related]
31. Tumor Cell Subtypes Based on the Intracellular Hormonal Activity in KCNJ5-Mutated Aldosterone-Producing Adenoma.
Yamazaki Y; Omata K; Tezuka Y; Ono Y; Morimoto R; Adachi Y; Ise K; Nakamura Y; Gomez-Sanchez CE; Shibahara Y; Kitamoto T; Nishikawa T; Ito S; Satoh F; Sasano H
Hypertension; 2018 Sep; 72(3):632-640. PubMed ID: 30354756
[TBL] [Abstract][Full Text] [Related]
32. Prevalence and characterization of somatic mutations in Chinese aldosterone-producing adenoma patients.
Wang B; Li X; Zhang X; Ma X; Chen L; Zhang Y; Lyu X; Tang Y; Huang Q; Gao Y; Fan Y; Ouyang J
Medicine (Baltimore); 2015 Apr; 94(16):e708. PubMed ID: 25906099
[TBL] [Abstract][Full Text] [Related]
33. Case Report: Primary Aldosteronism Due to Bilateral Aldosterone-Producing Micronodules With HISTALDO Classical and Contralateral Non-Classical Pathology.
Chen YJ; Peng KY; Chueh JS; Liao HW; Hsieh TY; Wu VC; Wang SM
Front Endocrinol (Lausanne); 2022; 13():816754. PubMed ID: 35399924
[TBL] [Abstract][Full Text] [Related]
34. Double adrenocortical adenomas harboring independent KCNJ5 and PRKACA somatic mutations.
Nanba K; Omata K; Tomlins SA; Giordano TJ; Hammer GD; Rainey WE; Else T
Eur J Endocrinol; 2016 Aug; 175(2):K1-6. PubMed ID: 27165862
[TBL] [Abstract][Full Text] [Related]
35. Pathogenesis of Primary Aldosteronism: Impact on Clinical Outcome.
Santana LS; Guimaraes AG; Almeida MQ
Front Endocrinol (Lausanne); 2022; 13():927669. PubMed ID: 35813615
[TBL] [Abstract][Full Text] [Related]
36. Primary Aldosteronism: Spatial Multiomics Mapping of Genotype-Dependent Heterogeneity and Tumor Expansion of Aldosterone-Producing Adenomas.
Gong S; Sun N; Meyer LS; Tetti M; Koupourtidou C; Krebs S; Masserdotti G; Blum H; Rainey WE; Reincke M; Walch A; Williams TA
Hypertension; 2023 Jul; 80(7):1555-1567. PubMed ID: 37125608
[TBL] [Abstract][Full Text] [Related]
37. Update on the Genetics of Primary Aldosteronism and Aldosterone-Producing Adenomas.
Pitsava G; Faucz FR; Stratakis CA; Hannah-Shmouni F
Curr Cardiol Rep; 2022 Sep; 24(9):1189-1195. PubMed ID: 35841527
[TBL] [Abstract][Full Text] [Related]
38. Clinical Translationality of
Kitamoto T; Nishikawa T
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012306
[TBL] [Abstract][Full Text] [Related]
39. Genetic disorders in primary aldosteronism-familial and somatic.
Funder JW
J Steroid Biochem Mol Biol; 2017 Jan; 165(Pt A):154-157. PubMed ID: 27013018
[TBL] [Abstract][Full Text] [Related]
40. Case Report: Nodule Development From Subcapsular Aldosterone-Producing Cell Clusters Causes Hyperaldosteronism.
Nishimoto K; Seki T; Kurihara I; Yokota K; Omura M; Nishikawa T; Shibata H; Kosaka T; Oya M; Suematsu M; Mukai K
J Clin Endocrinol Metab; 2016 Jan; 101(1):6-9. PubMed ID: 26580238
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]